Postop CV Morbidity Down With Increased Time From COVID-19 to Surgery
WEDNESDAY, Dec. 14, 2022 -- The odds of experiencing major postoperative cardiovascular morbidity are reduced with increased time from COVID-19 diagnosis to surgery, according to a study published online Dec. 14 in JAMA Network Open.
John M. Bryant,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | COVID-19 | Heart | Pharmaceuticals | Study